Global Drugs for Nonsmall Cell Lung Cancer Sales Market Report 2016

Global Drugs for Non-small Cell Lung Cancer Sales Market Report 2016

1 Drugs for Non-small Cell Lung Cancer Overview

1.1 Product Overview and Scope of Drugs for Non-small Cell Lung Cancer

1.2 Classification of Drugs for Non-small Cell Lung Cancer

1.2.1 Surgery

1.2.2 Radiofrequency ablation (RFA)

1.2.3 Radiation therapy

1.2.4 Chemotherapy

1.2.5 Targeted therapies

1.2.6 Immunotherapy

1.3 Application of Drugs for Non-small Cell Lung Cancer

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Drugs for Non-small Cell Lung Cancer Market by Regions

1.4.1 United States Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Drugs for Non-small Cell Lung Cancer (2011-2021)

1.5.1 Global Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2021)

1.5.2 Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

2 Global Drugs for Non-small Cell Lung Cancer Competition by Manufacturers, Type and Application

2.1 Global Drugs for Non-small Cell Lung Cancer Market Competition by Manufacturers

2.1.1 Global Drugs for Non-small Cell Lung Cancer Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Drugs for Non-small Cell Lung Cancer Revenue and Share by Manufacturers (2011-2016)

2.2 Global Drugs for Non-small Cell Lung Cancer (Volume and Value) by Type

2.2.1 Global Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type (2011-2016)

2.2.2 Global Drugs for Non-small Cell Lung Cancer Revenue and Market Share by Type (2011-2016)

2.3 Global Drugs for Non-small Cell Lung Cancer (Volume and Value) by Regions

2.3.1 Global Drugs for Non-small Cell Lung Cancer Sales and Market Share by Regions (2011-2016)

2.3.2 Global Drugs for Non-small Cell Lung Cancer Revenue and Market Share by Regions (2011-2016)

2.4 Global Drugs for Non-small Cell Lung Cancer (Volume) by Application

3 United States Drugs for Non-small Cell Lung Cancer (Volume, Value and Sales Price)

3.1 United States Drugs for Non-small Cell Lung Cancer Sales and Value (2011-2016)

3.1.1 United States Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

3.1.2 United States Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

3.1.3 United States Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

3.2 United States Drugs for Non-small Cell Lung Cancer Sales and Market Share by Manufacturers

3.3 United States Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type

3.4 United States Drugs for Non-small Cell Lung Cancer Sales and Market Share by Application

4 China Drugs for Non-small Cell Lung Cancer (Volume, Value and Sales Price)

4.1 China Drugs for Non-small Cell Lung Cancer Sales and Value (2011-2016)

4.1.1 China Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

4.1.2 China Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

4.1.3 China Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

4.2 China Drugs for Non-small Cell Lung Cancer Sales and Market Share by Manufacturers

4.3 China Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type

4.4 China Drugs for Non-small Cell Lung Cancer Sales and Market Share by Application

5 Europe Drugs for Non-small Cell Lung Cancer (Volume, Value and Sales Price)

5.1 Europe Drugs for Non-small Cell Lung Cancer Sales and Value (2011-2016)

5.1.1 Europe Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

5.1.2 Europe Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

5.1.3 Europe Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

5.2 Europe Drugs for Non-small Cell Lung Cancer Sales and Market Share by Manufacturers

5.3 Europe Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type

5.4 Europe Drugs for Non-small Cell Lung Cancer Sales and Market Share by Application

6 Japan Drugs for Non-small Cell Lung Cancer (Volume, Value and Sales Price)

6.1 Japan Drugs for Non-small Cell Lung Cancer Sales and Value (2011-2016)

6.1.1 Japan Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

6.1.2 Japan Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

6.1.3 Japan Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

6.2 Japan Drugs for Non-small Cell Lung Cancer Sales and Market Share by Manufacturers

6.3 Japan Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type

6.4 Japan Drugs for Non-small Cell Lung Cancer Sales and Market Share by Application

7 Global Drugs for Non-small Cell Lung Cancer Manufacturers Analysis

7.1 Bristol-Myers Squibb

7.1.1 Company Basic Information, Manufacturing Base and Competitors

7.1.2 Drugs for Non-small Cell Lung Cancer Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.1.4 Main Business/Business Overview

7.2 GlaxoSmithKline

7.2.1 Company Basic Information, Manufacturing Base and Competitors

7.2.2 126 Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.2.4 Main Business/Business Overview

7.3 Menarini

7.3.1 Company Basic Information, Manufacturing Base and Competitors

7.3.2 140 Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Menarini Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.3.4 Main Business/Business Overview

7.4 Sanofi

7.4.1 Company Basic Information, Manufacturing Base and Competitors

7.4.2 Dec Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Sanofi Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.4.4 Main Business/Business Overview

7.5 ZIOPHARM Oncology

7.5.1 Company Basic Information, Manufacturing Base and Competitors

7.5.2 Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 ZIOPHARM Oncology Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.5.4 Main Business/Business Overview

7.6 Alchemia

7.6.1 Company Basic Information, Manufacturing Base and Competitors

7.6.2 Million USD Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Alchemia Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.6.4 Main Business/Business Overview

7.7 Amgen

7.7.1 Company Basic Information, Manufacturing Base and Competitors

7.7.2 Pharma & Healthcare Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Amgen Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.7.4 Main Business/Business Overview

7.8 Apotex

7.8.1 Company Basic Information, Manufacturing Base and Competitors

7.8.2 Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Apotex Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.8.4 Main Business/Business Overview

7.9 BioMarin Pharmaceutical

7.9.1 Company Basic Information, Manufacturing Base and Competitors

7.9.2 Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.9.4 Main Business/Business Overview

7.10 CellAct Pharma

7.10.1 Company Basic Information, Manufacturing Base and Competitors

7.10.2 Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 CellAct Pharma Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

7.10.4 Main Business/Business Overview

7.11 Cerulean Pharma

7.12 Cipla

7.13 Cornerstone Pharmaceuticals

7.14 Curis

7.15 CytRx

7.16 Eli Lilly

7.17 Exelixis

7.18 Fresenius Kabi

7.19 Genentech

7.20 Hikma Pharmaceuticals

7.21 Hospira

7.22 Intas Pharmaceuticals

7.23 Karyopharm Therapeutics

7.24 Kyowa Hakko Kirin

7.25 Ligand Pharmaceuticals

8 Drugs for Non-small Cell Lung Cancer Maufacturing Cost Analysis

8.1 Drugs for Non-small Cell Lung Cancer Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Process Analysis of Drugs for Non-small Cell Lung Cancer

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Drugs for Non-small Cell Lung Cancer Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Drugs for Non-small Cell Lung Cancer Market Forecast (2016-2021)

12.1 Global Drugs for Non-small Cell Lung Cancer Sales, Revenue Forecast (2016-2021)

12.2 Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Regions (2016-2021)

12.3 Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type (2016-2021)

12.4 Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application (2016-2021)

13 Appendix

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Drugs for Non-small Cell Lung Cancer

Table Classification of Drugs for Non-small Cell Lung Cancer

Figure Global Sales Market Share of Drugs for Non-small Cell Lung Cancer by Type in 2015

Figure Surgery Picture

Figure Radiofrequency ablation (RFA) Picture

Figure Radiation therapy Picture

Figure Chemotherapy Picture

Figure Targeted therapies Picture

Figure Immunotherapy Picture

Table Applications of Drugs for Non-small Cell Lung Cancer

Figure Global Sales Market Share of Drugs for Non-small Cell Lung Cancer by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure United States Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

Figure China Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

Figure Europe Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

Figure Japan Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

Figure Global Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2021)

Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2021)

Table Global Drugs for Non-small Cell Lung Cancer Sales of Key Manufacturers (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales Share by Manufacturers (2011-2016)

Figure 2015 Drugs for Non-small Cell Lung Cancer Sales Share by Manufacturers

Figure 2016 Drugs for Non-small Cell Lung Cancer Sales Share by Manufacturers

Table Global Drugs for Non-small Cell Lung Cancer Revenue by Manufacturers (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Drugs for Non-small Cell Lung Cancer Revenue Share by Manufacturers

Table 2016 Global Drugs for Non-small Cell Lung Cancer Revenue Share by Manufacturers

Table Global Drugs for Non-small Cell Lung Cancer Sales and Market Share by Type (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales Share by Type (2011-2016)

Figure Sales Market Share of Drugs for Non-small Cell Lung Cancer by Type (2011-2016)

Figure Global Drugs for Non-small Cell Lung Cancer Sales Growth Rate by Type (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Revenue and Market Share by Type (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Drugs for Non-small Cell Lung Cancer by Type (2011-2016)

Figure Global Drugs for Non-small Cell Lung Cancer Revenue Growth Rate by Type (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales and Market Share by Regions (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales Share by Regions (2011-2016)

Figure Sales Market Share of Drugs for Non-small Cell Lung Cancer by Regions (2011-2016)

Figure Global Drugs for Non-small Cell Lung Cancer Sales Growth Rate by Regions (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Revenue and Market Share by Regions (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Drugs for Non-small Cell Lung Cancer by Regions (2011-2016)

Figure Global Drugs for Non-small Cell Lung Cancer Revenue Growth Rate by Regions (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales and Market Share by Application (2011-2016)

Table Global Drugs for Non-small Cell Lung Cancer Sales Share by Application (2011-2016)

Figure Sales Market Share of Drugs for Non-small Cell Lung Cancer by Application (2011-2016)

Figure Global Drugs for Non-small Cell Lung Cancer Sales Growth Rate by Application (2011-2016)

Figure United States Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

Figure United States Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

Figure United States Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Sales by Manufacturers (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Market Share by Manufacturers (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Sales by Type (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Market Share by Type (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Sales by Application (2011-2016)

Table United States Drugs for Non-small Cell Lung Cancer Market Share by Application (2011-2016)

Figure China Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

Figure China Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

Figure China Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Sales by Manufacturers (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Market Share by Manufacturers (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Sales by Type (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Market Share by Type (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Sales by Application (2011-2016)

Table China Drugs for Non-small Cell Lung Cancer Market Share by Application (2011-2016)

Figure Europe Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

Figure Europe Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

Figure Europe Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Sales by Manufacturers (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Manufacturers (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Sales by Type (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Type (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Sales by Application (2011-2016)

Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Application (2011-2016)

Figure Japan Drugs for Non-small Cell Lung Cancer Sales and Growth Rate (2011-2016)

Figure Japan Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2011-2016)

Figure Japan Drugs for Non-small Cell Lung Cancer Sales Price Trend (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Sales by Manufacturers (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Market Share by Manufacturers (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Sales by Type (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Market Share by Type (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Sales by Application (2011-2016)

Table Japan Drugs for Non-small Cell Lung Cancer Market Share by Application (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Menarini Basic Information List

Table Menarini Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Menarini Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table ZIOPHARM Oncology Basic Information List

Table ZIOPHARM Oncology Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ZIOPHARM Oncology Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Alchemia Basic Information List

Table Alchemia Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alchemia Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Apotex Basic Information List

Table Apotex Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Apotex Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table BioMarin Pharmaceutical Basic Information List

Table BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table CellAct Pharma Basic Information List

Table CellAct Pharma Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CellAct Pharma Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Cerulean Pharma Basic Information List

Table Cerulean Pharma Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cerulean Pharma Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Cipla Basic Information List

Table Cipla Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cipla Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Cornerstone Pharmaceuticals Basic Information List

Table Cornerstone Pharmaceuticals Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cornerstone Pharmaceuticals Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Curis Basic Information List

Table Curis Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Curis Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table CytRx Basic Information List

Table CytRx Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CytRx Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Exelixis Basic Information List

Table Exelixis Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Exelixis Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Fresenius Kabi Basic Information List

Table Fresenius Kabi Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Fresenius Kabi Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Hikma Pharmaceuticals Basic Information List

Table Hikma Pharmaceuticals Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hikma Pharmaceuticals Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Hospira Basic Information List

Table Hospira Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hospira Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Intas Pharmaceuticals Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Karyopharm Therapeutics Basic Information List

Table Karyopharm Therapeutics Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Karyopharm Therapeutics Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Kyowa Hakko Kirin Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Ligand Pharmaceuticals Basic Information List

Table Ligand Pharmaceuticals Drugs for Non-small Cell Lung Cancer Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Ligand Pharmaceuticals Drugs for Non-small Cell Lung Cancer Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Non-small Cell Lung Cancer

Figure Manufacturing Process Analysis of Drugs for Non-small Cell Lung Cancer

Figure Drugs for Non-small Cell Lung Cancer Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015

Table Major Buyers of Drugs for Non-small Cell Lung Cancer

Table Distributors/Traders List

Figure Global Drugs for Non-small Cell Lung Cancer Sales and Growth Rate Forecast (2016-2021)

Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast (2016-2021)

Table Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Regions (2016-2021)

Table Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type (2016-2021)

Table Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application (2016-2021)